Skip to content
healthcare.dev
Get a free key

Eslicarbazepine Acetate

NDC 68180-293, Eslicarbazepine Acetate, tablet, from Lupin Pharmaceuticals, Inc..

Product NDC
68180-293
Status
Listed
Labeler
Lupin Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211246
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68180-293 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ESLICARBAZEPINE ACETATE800 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
68180-293-066818002930630 TABLET in 1 BOTTLE (68180-293-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/999b341f-fe13-4dd9-bb95-9b0d6a817c4c

  • NADAC price for package 68180029306

    GET /v1/drugs/nadac/68180029306

Use it

Look up 68180-293 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68180-293 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68180-293. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.